Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting. - Dutoit,V.; Taub,R.N.; Papadopoulos,K.P.; Talbot,S.; Keohan,M.L.; Brehm,M.; Gnjatic,S.; Harris,P.E.; Bisikirska,B.; Guillaume,P. (J Clin Invest, 2002)